US Stock MarketDetailed Quotes

ENTX Entera Bio

Watchlist
  • 2.0000
  • -0.0900-4.31%
Close Jun 7 16:00 ET
  • 2.0200
  • +0.0200+1.00%
Post 19:33 ET
71.57MMarket Cap-7142P/E (TTM)

Entera Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-15.72%-1.86M
41.52%-7.31M
-30.13%-2.62M
46.85%-1.53M
44.85%-1.56M
66.42%-1.61M
-37.91%-12.5M
19.94%-2.01M
-36.04%-2.87M
-33.29%-2.83M
Net income from continuing operations
7.90%-2.02M
31.99%-8.89M
34.27%-2M
22.43%-2.38M
27.00%-2.33M
42.12%-2.19M
-7.25%-13.07M
25.98%-3.04M
4.57%-3.07M
-23.59%-3.19M
Depreciation and amortization
-7.14%13K
-12.50%56K
-18.75%13K
-12.50%14K
-6.25%15K
-12.50%14K
20.75%64K
14.29%16K
6.67%16K
6.67%16K
Deferred tax
----
-83.33%29K
--0
-86.45%29K
----
----
180.18%174K
145.10%23K
475.44%214K
47.37%-30K
Other non cash items
-200.00%-9K
----
----
-366.67%-14K
90.63%-3K
92.31%-3K
-533.33%-78K
-116.67%-4K
-50.00%-3K
-313.33%-32K
Change In working capital
-679.63%-313K
89.37%-195K
-290.04%-973K
417.99%442K
196.58%282K
102.82%54K
-230.23%-1.84M
-58.48%512K
-126.68%-139K
-430.91%-292K
-Change in receivables
--0
490.48%246K
--0
462.50%29K
--0
903.70%217K
-187.50%-63K
-118.84%-13K
94.12%-8K
85.15%-15K
-Change in payables and accrued expense
-94.39%11K
71.05%-497K
-717.84%-1.14M
137.58%171K
141.52%279K
125.29%196K
-216.56%-1.72M
-80.40%185K
-274.33%-455K
-450.82%-672K
-Change in other current assets
9.75%-324K
240.00%56K
-50.00%170K
-25.31%242K
-99.24%3K
67.33%-359K
-671.43%-40K
65.85%340K
-19.80%324K
125.71%395K
-Change in other working capital
----
----
----
----
----
----
89.51%-15K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-15.72%-1.86M
41.52%-7.31M
-30.13%-2.62M
46.85%-1.53M
44.85%-1.56M
66.42%-1.61M
-37.91%-12.5M
19.94%-2.01M
-36.04%-2.87M
-33.29%-2.83M
Investing cash flow
Cash flow from continuing investing activities
0
83.33%-17K
-66.67%-5K
0
94.74%-1K
52.17%-11K
-500.00%-102K
70.00%-3K
-714.29%-57K
-19K
Net PPE purchase and sale
--0
63.83%-17K
-66.67%-5K
--0
94.74%-1K
52.17%-11K
-176.47%-47K
70.00%-3K
71.43%-2K
---19K
Net other investing changes
----
----
----
----
----
----
---55K
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
83.33%-17K
-66.67%-5K
--0
94.74%-1K
52.17%-11K
-500.00%-102K
70.00%-3K
-714.29%-57K
---19K
Financing cash flow
Cash flow from continuing financing activities
30K
46,330.77%6.04M
6.03M
0
5K
0
-99.95%13K
0
0
Net common stock issuance
----
--6.62M
--6.61M
--0
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
--30K
--0
--0
--0
--0
--0
-99.64%13K
--0
--0
----
Net other financing activities
----
---580K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--30K
46,330.77%6.04M
--6.03M
--0
--5K
--0
-99.95%13K
--0
--0
----
Net cash flow
Beginning cash position
-10.43%11.09M
-50.42%12.38M
-46.66%7.68M
-46.86%9.2M
-46.62%10.76M
-50.42%12.38M
188.17%24.96M
-47.61%14.39M
-35.86%17.32M
22.48%20.15M
Current changes in cash
-13.09%-1.83M
89.74%-1.29M
269.27%3.41M
47.88%-1.53M
45.11%-1.56M
66.36%-1.62M
-177.22%-12.59M
19.47%-2.01M
-723.88%-2.93M
-126.87%-2.83M
End cash Position
-13.97%9.25M
-10.43%11.09M
-10.43%11.09M
-46.66%7.68M
-46.86%9.2M
-46.62%10.76M
-50.42%12.38M
-50.42%12.38M
-47.61%14.39M
-35.86%17.32M
Free cash flow
-14.94%-1.86M
41.60%-7.33M
-30.19%-2.62M
46.88%-1.53M
45.19%-1.56M
66.36%-1.62M
-38.17%-12.55M
20.14%-2.01M
-35.68%-2.87M
-34.18%-2.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -15.72%-1.86M41.52%-7.31M-30.13%-2.62M46.85%-1.53M44.85%-1.56M66.42%-1.61M-37.91%-12.5M19.94%-2.01M-36.04%-2.87M-33.29%-2.83M
Net income from continuing operations 7.90%-2.02M31.99%-8.89M34.27%-2M22.43%-2.38M27.00%-2.33M42.12%-2.19M-7.25%-13.07M25.98%-3.04M4.57%-3.07M-23.59%-3.19M
Depreciation and amortization -7.14%13K-12.50%56K-18.75%13K-12.50%14K-6.25%15K-12.50%14K20.75%64K14.29%16K6.67%16K6.67%16K
Deferred tax -----83.33%29K--0-86.45%29K--------180.18%174K145.10%23K475.44%214K47.37%-30K
Other non cash items -200.00%-9K---------366.67%-14K90.63%-3K92.31%-3K-533.33%-78K-116.67%-4K-50.00%-3K-313.33%-32K
Change In working capital -679.63%-313K89.37%-195K-290.04%-973K417.99%442K196.58%282K102.82%54K-230.23%-1.84M-58.48%512K-126.68%-139K-430.91%-292K
-Change in receivables --0490.48%246K--0462.50%29K--0903.70%217K-187.50%-63K-118.84%-13K94.12%-8K85.15%-15K
-Change in payables and accrued expense -94.39%11K71.05%-497K-717.84%-1.14M137.58%171K141.52%279K125.29%196K-216.56%-1.72M-80.40%185K-274.33%-455K-450.82%-672K
-Change in other current assets 9.75%-324K240.00%56K-50.00%170K-25.31%242K-99.24%3K67.33%-359K-671.43%-40K65.85%340K-19.80%324K125.71%395K
-Change in other working capital ------------------------89.51%-15K--0--0--0
Cash from discontinued investing activities
Operating cash flow -15.72%-1.86M41.52%-7.31M-30.13%-2.62M46.85%-1.53M44.85%-1.56M66.42%-1.61M-37.91%-12.5M19.94%-2.01M-36.04%-2.87M-33.29%-2.83M
Investing cash flow
Cash flow from continuing investing activities 083.33%-17K-66.67%-5K094.74%-1K52.17%-11K-500.00%-102K70.00%-3K-714.29%-57K-19K
Net PPE purchase and sale --063.83%-17K-66.67%-5K--094.74%-1K52.17%-11K-176.47%-47K70.00%-3K71.43%-2K---19K
Net other investing changes ---------------------------55K--0--------
Cash from discontinued investing activities
Investing cash flow --083.33%-17K-66.67%-5K--094.74%-1K52.17%-11K-500.00%-102K70.00%-3K-714.29%-57K---19K
Financing cash flow
Cash flow from continuing financing activities 30K46,330.77%6.04M6.03M05K0-99.95%13K00
Net common stock issuance ------6.62M--6.61M--0----------0--0--0----
Proceeds from stock option exercised by employees --30K--0--0--0--0--0-99.64%13K--0--0----
Net other financing activities -------580K--------------------------------
Cash from discontinued financing activities
Financing cash flow --30K46,330.77%6.04M--6.03M--0--5K--0-99.95%13K--0--0----
Net cash flow
Beginning cash position -10.43%11.09M-50.42%12.38M-46.66%7.68M-46.86%9.2M-46.62%10.76M-50.42%12.38M188.17%24.96M-47.61%14.39M-35.86%17.32M22.48%20.15M
Current changes in cash -13.09%-1.83M89.74%-1.29M269.27%3.41M47.88%-1.53M45.11%-1.56M66.36%-1.62M-177.22%-12.59M19.47%-2.01M-723.88%-2.93M-126.87%-2.83M
End cash Position -13.97%9.25M-10.43%11.09M-10.43%11.09M-46.66%7.68M-46.86%9.2M-46.62%10.76M-50.42%12.38M-50.42%12.38M-47.61%14.39M-35.86%17.32M
Free cash flow -14.94%-1.86M41.60%-7.33M-30.19%-2.62M46.88%-1.53M45.19%-1.56M66.36%-1.62M-38.17%-12.55M20.14%-2.01M-35.68%-2.87M-34.18%-2.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg